<DOC>
	<DOCNO>NCT00781092</DOCNO>
	<brief_summary>The primary objective study compare two post operative drop regimens management dry eye control heal use FDA-approved ophthalmic solution .</brief_summary>
	<brief_title>A Prospective , Randomized , Double-Masked , Single Center , Clinical Comparison Use Systane Ultra Management Dry Eyes Bilateral Eyes</brief_title>
	<detailed_description>This comparison make bilateral eye patient follow excimer laser ablation use FDA-approved LADARVision 4000 Excimer Laser System WaveLight ALLEGRETTO WAVEâ„¢ Excimer Laser System . Post operative questionnaire regard use drop compare . Tear osmolarity tear breakup time evaluate use Tear Lab OQAS II .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects must suitable candidate FDA Approved LASIK . Subjects must stable refraction document previous clinical record . Subjects wear soft contact lenses must discontinue wear least 3 day prior preoperative exam surgery . Subjects wear gas permeable contact lenses must discontinue wear least 3 week prior preoperative exam surgery . Subjects must least 18 year age . Subjects must willing able return schedule follow examination day surgery specify time . Subjects must sign give copy write Informed Consent form . Subjects either eye meet inclusion criterion either eye meet exclusion criterion . Subjects clinically significant dry eye syndrome clinically significant blepharitis either eye . Subjects clinically significant anterior segment pathology , include clinically significant cataract , corneal scar neovascularization either eye . Subjects undergone previous intraocular corneal surgery kind , include type surgery either refractive therapeutic purpose either eye . Subjects history Herpes zoster Herpes simplex keratitis . Subjects chronic systemic corticosteroid immunosuppressive therapy may affect wound healing , immunocompromised subject , subject clinically significant atopic disease , connective tissue disease , uncontrolled diabetes . Subjects history steroidresponsive rise intraocular pressure , glaucoma , preoperative IOP &gt; 25 mm Hg either eye . Subjects macular pathology either eye . Subjects pregnant , lactating , plan pregnant course study . Subjects know sensitivity plan study concomitant medication . Subjects participate ophthalmic drug device clinical trial time clinical investigation . Use ocular drug , study medication , study within 30 day prior study entry ocular medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Dry Eyes</keyword>
	<keyword>LASIK</keyword>
	<keyword>Laser Vision Correction</keyword>
</DOC>